MedPath

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis

Phase 4
Completed
Conditions
Liver Cirrhosis
Interventions
Dietary Supplement: Branched-chain aminoacids
Other: High-fiber high protein diet
Registration Number
NCT02023229
Lead Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Brief Summary

Malnutrition is a frequent complication in patients with liver cirrhosis. Most patients have decreased dietary intake due to ascites, hepatic encephalopathy and pro-inflammatory cytokines.

We hypothesized that branched chain aminoacids can improve nutritional status and delay episodes of hepatic encephalopathy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria

Ambulatory patients Patients with confirmed diagnose of liver cirrhosis Patients classified as Child-Pugh A or Child Pugh B

Exclusion Criteria

Acute or chronic renal failure Pregnancy Overt hepatic encephalopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diet plus branched chain aminoacidsBranched-chain aminoacidsHigh-fiber high-protein diet Oral supplement : branched chain aminoacids
Diet plus branched chain aminoacidsHigh-fiber high protein dietHigh-fiber high-protein diet Oral supplement : branched chain aminoacids
DietHigh-fiber high protein dietHigh-fiber high-protein diet
Primary Outcome Measures
NameTimeMethod
Nutritional statusAt time of recruitment

Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference

Secondary Outcome Measures
NameTimeMethod
Hepatic EncephalopathyAt time of recruitment

Trial Locations

Locations (1)

Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"

🇲🇽

Mexico city, Mexico

© Copyright 2025. All Rights Reserved by MedPath